Immunogenicity and Safety of an EB66 Cell-Culture-Derived Influenza A/Indonesia/5/2005(H5N1) AS03-Adjuvanted Vaccine: A Phase 1 Randomized Trial

por Schuind, Anne, Segall, Nathan, Drame, Mamadou, Innis, Bruce L.
Publicado 2015

Evaluation of potential immunogenicity differences between Pandemrix™ and Arepanrix™

por Canelle, Quentin, Dewé, Walthère, Innis, Bruce L., van der Most, Robbert
Publicado 2016

Vital sign predictors of severe influenza among children in an emergent care setting

por Rao, Suchitra, Moss, Angela, Lamb, Molly, Innis, Bruce L., Asturias, Edwin J.
Publicado 2022

Genetic characterization of early isolates of Japanese encephalitis virus: genotype II has been circulating since at least 1951

por Schuh, Amy J., Li, Li, Tesh, Robert B., Innis, Bruce L., Barrett, Alan D. T.
Publicado 2010

A historically-controlled Phase III study in adults to characterize the acceptability of a process change for manufacturing inactivated quadrivalent influenza vaccine

por Jain, Varsha K, Chandrasekaran, Vijayalakshmi, Wang, Long, Li, Ping, Liu, Aixue, Innis, Bruce L
Publicado 2014

Immunogenicity and Safety of an Inactivated Quadrivalent Influenza Vaccine in US Children 6–35 Months of Age During 2013–2014: Results From A Phase II Randomized Trial

por Wang, Long, Chandrasekaran, Vijayalakshmi, Domachowske, Joseph B., Li, Ping, Innis, Bruce L., Jain, Varsha K.
Publicado 2016

A review of the value of quadrivalent influenza vaccines and their potential contribution to influenza control

por Ray, Riju, Dos Santos, Gaël, Buck, Philip O., Claeys, Carine, Matias, Gonçalo, Innis, Bruce L., Bekkat-Berkani, Rafik
Publicado 2017

2319. Clinical Predictors of Influenza and Hospitalization of Children with Influenza in an Emergent Care Setting

por Rao, Suchitra, Lamb, Molly, Moss, Angela, Yanni, Emad, Bekkat-Berkani, Rafik, Schuind, Anne, Innis, Bruce, Asturias, Edwin J
Publicado 2019

A Randomized Trial of Candidate Inactivated Quadrivalent Influenza Vaccine versus Trivalent Influenza Vaccines in Children Aged 3–17 Years

por Domachowske, Joseph B., Pankow-Culot, Heidemarie, Bautista, Milagros, Feng, Yang, Claeys, Carine, Peeters, Mathieu, Innis, Bruce L., Jain, Varsha
Publicado 2013

Closer and closer? Maternal immunization: current promise, future horizons

por Engmann, Cyril, Fleming, Jessica A., Khan, Sadaf, Innis, Bruce L., Smith, Jeffrey M., Hombach, Joachim, Sobanjo-ter Meulen, Ajoke
Publicado 2020

AS03(B)-Adjuvanted H5N1 Influenza Vaccine in Children 6 Months Through 17 Years of Age: A Phase 2/3 Randomized, Placebo-Controlled, Observer-Blinded Trial

por Kosalaraksa, Pope, Jeanfreau, Robert, Frenette, Louise, Drame, Mamadou, Madariaga, Miguel, Innis, Bruce L., Godeaux, Olivier, Izurieta, Patricia, Vaughn, David W.
Publicado 2015

Immunogenicity and Safety of an AS03-Adjuvanted H7N9 Pandemic Influenza Vaccine in a Randomized Trial in Healthy Adults

por Madan, Anuradha, Segall, Nathan, Ferguson, Murdo, Frenette, Louise, Kroll, Robin, Friel, Damien, Soni, Jyoti, Li, Ping, Innis, Bruce L., Schuind, Anne
Publicado 2016

Safety of AS03-adjuvanted inactivated split virion A(H1N1)pdm09 and H5N1 influenza virus vaccines administered to adults: Pooled analysis of 28 clinical trials

por Vaughn, David W, Seifert, Harry, Hepburn, Anne, Dewe, Walthere, Li, Ping, Drame, Mamadou, Cohet, Catherine, Innis, Bruce L, Fries, Louis F
Publicado 2014

A chimeric haemagglutinin-based influenza split virion vaccine adjuvanted with AS03 induces protective stalk-reactive antibodies in mice

por Nachbagauer, Raffael, Kinzler, David, Choi, Angela, Hirsh, Ariana, Beaulieu, Edith, Lecrenier, Nicolas, Innis, Bruce L, Palese, Peter, Mallett, Corey P, Krammer, Florian
Publicado 2016

986. Evaluation of Moderate-to-Severe Influenza Disease in Children 6 Months to 8 Years of Age in Colorado

por Rao, Suchitra, Lamb, Molly, Moss, Angela, Yanni, Emad, Bekkat-Berkani, Rafik, Schuind, Anne, Innis, Bruce, Cotter, Jillian, Mistry, Rakesh, Asturias, Edwin J
Publicado 2018

Challenge of conducting a placebo-controlled randomized efficacy study for influenza vaccine in a season with low attack rate and a mismatched vaccine B strain: a concrete example

por Beran, Jiří, Wertzova, Veronika, Honegr, Karel, Kaliskova, Eva, Havlickova, Martina, Havlik, Jiří, Jirincova, Helena, Van Belle, Pascale, Jain, Varsha, Innis, Bruce, Devaster, Jeanne-Marie
Publicado 2009

Meeting report: Convening on the influenza human viral challenge model for universal influenza vaccines, Part 1: Value; challenge virus selection; regulatory, industry and ethical...

por Innis, Bruce L., Berlanda Scorza, Francesco, Blum, Jeremy S., Jain, Varsha K., Older Aguilar, Anastazia, Post, Diane J., Roberts, Paul C., Wairagkar, Niteen, White, Janet, Bresee, Joseph
Publicado 2019

Chimeric Hemagglutinin-Based Live-Attenuated Vaccines Confer Durable Protective Immunity against Influenza A Viruses in a Preclinical Ferret Model

por Liu, Wen-Chun, Nachbagauer, Raffael, Stadlbauer, Daniel, Strohmeier, Shirin, Solórzano, Alicia, Berlanda-Scorza, Francesco, Innis, Bruce L., García-Sastre, Adolfo, Palese, Peter, Krammer, Florian, Albrecht, Randy A.
Publicado 2021

Association Between Hemagglutination Inhibition Antibody Titers and Protection Against Reverse-Transcription Polymerase Chain Reaction–Confirmed Influenza Illness in Children 6–35...

por Danier, Jasur, Callegaro, Andrea, Soni, Jyoti, Carmona, Alfoso, Kosalaraska, Pope, Rivera, Luis, Friel, Damien, Pu, Wenji, Vantomme, Valerie, Dbaibo, Ghassan, Innis, Bruce L, Schuind, Anne, Zaman, Khalequ, Wilson, Jerome
Publicado 2021

A Phase II, Randomized, Safety and Immunogenicity Study of a Re-Derived, Live-Attenuated Dengue Virus Vaccine in Healthy Adults

por Thomas, Stephen J., Eckels, Kenneth H., Carletti, Isabelle, De La Barrera, Rafael, Dessy, Francis, Fernandez, Stefan, Putnak, Robert, Toussaint, Jean-Francois, Sun, Wellington, Bauer, Kristen, Gibbons, Robert V., Innis, Bruce L.
Publicado 2013